tocophersolan has been researched along with Lung Neoplasms in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 19 (79.17) | 24.3611 |
| 2020's | 5 (20.83) | 2.80 |
| Authors | Studies |
|---|---|
| Chinni, S; Kala, SG | 1 |
| Lin, X; Wang, H; Wu, Y | 1 |
| Gou, G; Li, N; Liu, Q; Mai, Y; Yang, J | 1 |
| Cheng, X; He, L; Song, J; Sun, M; Tang, R; Wang, X; Wei, B; Xiong, N; Xu, J | 1 |
| Agrawal, N; Azad, S; Jha, A; Mahto, SK; Muthu, MS; Poddar, S; Viswanadh, MK | 1 |
| Cheng, W; Gao, N; Liang, C; Liu, G; Luo, L; Mei, L; Tao, W; Wang, X; Xu, L; Zeng, X; Zhang, X; Zuo, Y | 1 |
| Jin, X; Yang, Q; Zhang, Y | 1 |
| Chen, L; Chen, Y; Shan, R; Wu, X; Xu, G | 1 |
| Qi, Y; Qiao, Q; Qin, X; Song, Q; Wu, T; Yang, C; Zhang, Z | 1 |
| Du, X; Gu, X; Li, J; Wang, G; Xu, J; Yin, S; Zhou, F | 1 |
| Cao, L; Hao, K; Liu, F; Lu, G; Wang, B; Xia, N; Xie, H; Zhang, Y; Zhu, C | 1 |
| Huang, B; Liu, CS; Wang, G; Wu, Y; Yu, B; Yuan, Y | 1 |
| Chen, H; Dong, Y; Huang, H; Zhang, J; Zhang, W; Zhao, T; Zhu, J | 1 |
| Chen, L; Li, Y; Shen, J; Xu, P; Yin, Q; Yu, H; Zhang, Z | 1 |
| Li, Y; Meng, Q; Shen, J; Sui, H; Yin, Q; Yu, H; Zhang, Z | 1 |
| Ishak, RA; Osman, R | 1 |
| Chang, D; Chen, Y; Huang, L; Mei, L; Tao, W; Wang, T; Zeng, X; Zhang, J; Zhang, X | 1 |
| Bao, Y; Chu, Q; Tan, S; Wu, T; Wu, Y; Zhang, Z; Zhuang, X | 1 |
| Koch, B; Kumar, M; Muthu, MS; Pandey, BL; Sharma, G; Singh, RP; Singh, S | 1 |
| Jia, X; Song, J; Wei, P; Yan, H; Zhang, Z | 1 |
| Che, D; Jin, X; Pei, B; Tong, D; Xia, X; Yuan, G; Zhang, Y | 1 |
| Jia, X; Song, J; Yan, H; Zhang, Z | 1 |
| Gill, KK; Kaddoumi, A; Nazzal, S | 1 |
| Chen, L; Li, Y; Shen, J; Yin, Q; Zhang, Z | 1 |
24 other study(ies) available for tocophersolan and Lung Neoplasms
| Article | Year |
|---|---|
Bioavailability enhancement of vitamin E TPGS liposomes of nintedanib esylate: formulation optimization, cytotoxicity and pharmacokinetic studies.
Topics: Animals; Biological Availability; Carcinoma, Non-Small-Cell Lung; Drug Carriers; Indoles; Liposomes; Lung Neoplasms; Male; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Succinates; Vitamin E | 2022 |
Crizotinib loaded polydopamine-polylactide-TPGS nanoparticles in targeted therapy for non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Crizotinib; Humans; Lung Neoplasms; Nanoparticles | 2022 |
Docetaxel-loaded D-α-tocopheryl polyethylene glycol-1000 succinate liposomes improve lung cancer chemotherapy and reverse multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Liposomes; Lung Neoplasms; Mice; Mice, Nude; Polyethylene Glycols; Succinates; Vitamin E | 2021 |
Hybrid micelles based on Pt (IV) polymeric prodrug and TPGS for the enhanced cytotoxicity in drug-resistant lung cancer cells.
Topics: Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Micelles; Polymers; Prodrugs; Vitamin E | 2020 |
Novel redox-sensitive thiolated TPGS based nanoparticles for EGFR targeted lung cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; ErbB Receptors; Lung Neoplasms; Mice; Nanoparticles; Oxidation-Reduction; Particle Size; Polyethylene Glycols; Rats; Vitamin E | 2021 |
TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance.
Topics: A549 Cells; Drug Delivery Systems; Humans; Indoles; Lung Neoplasms; Microscopy, Electron, Transmission; Nanoparticles; Photoelectron Spectroscopy; Polyethylene Glycols; Polymers; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared; Vitamin E | 2017 |
Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apigenin; Cell Line, Tumor; Drug Combinations; Humans; Liposomes; Lung Neoplasms; Male; Mice, Nude; Oligopeptides; Vitamin E; Xenograft Model Antitumor Assays | 2017 |
Transferrin and tocopheryl-polyethylene glycol-succinate dual ligands decorated, cisplatin loaded nano-sized system for the treatment of lung cancer.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cisplatin; Drug Liberation; Endocytosis; Humans; Ligands; Lung Neoplasms; Mice, Nude; Nanoparticles; Palmitic Acid; Particle Size; Polyesters; Proton Magnetic Resonance Spectroscopy; Static Electricity; Tissue Distribution; Transferrin; Vitamin E | 2018 |
Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Hydrazines; Indazoles; Lung; Lung Neoplasms; MCF-7 Cells; Mice; Mice, Inbred BALB C; Micelles; Nanomedicine; Nitric Oxide; Rats; Rats, Sprague-Dawley; Tissue Distribution; Treatment Outcome; Vitamin E; Xenograft Model Antitumor Assays | 2018 |
Reduction-sensitive mixed micelles for selective intracellular drug delivery to tumor cells and reversal of multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Hyaluronic Acid; Lung Neoplasms; Mice; Micelles; Polyesters; Rats, Sprague-Dawley; Vitamin E | 2018 |
Improving lung cancer treatment: Hyaluronic acid‑modified and glutathione‑responsive amphiphilic TPGS‑doxorubicin prodrug‑entrapped nanoparticles.
Topics: A549 Cells; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Female; Glutathione; Humans; Hyaluronic Acid; Lung Neoplasms; Mice; Nanoparticles; Particle Size; Prodrugs; Theranostic Nanomedicine; Vitamin E; Xenograft Model Antitumor Assays | 2019 |
Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chemical Precipitation; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Female; Humans; Lactic Acid; Lung Neoplasms; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome; Tumor Burden; Vitamin E; Xenograft Model Antitumor Assays | 2013 |
Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Survival; Coumarins; Drug Delivery Systems; Humans; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Paclitaxel; Polyesters; Polyethylene Glycols; Thiazoles; Vitamin E; Xenograft Model Antitumor Assays | 2013 |
Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
Topics: Animals; Antineoplastic Agents; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Drug Synergism; Female; Humans; Lung Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Nude; Nanoparticles; Neoplasm Invasiveness; Particle Size; Phosphatidylcholines; Polyethylene Glycols; Silybin; Silymarin; Snail Family Transcription Factors; Solubility; Technology, Pharmaceutical; Time Factors; Tissue Distribution; Transcription Factors; Vitamin E; Wound Healing; Xenograft Model Antitumor Assays | 2013 |
iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Inhibitor of Apoptosis Proteins; Integrin alphaVbeta3; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Nanotechnology; Oligopeptides; Paclitaxel; Permeability; Polyethylene Glycols; RNA Interference; RNA, Small Interfering; Survivin; Vitamin E | 2014 |
Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
Topics: Administration, Inhalation; Aerosols; Atorvastatin; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Desiccation; Dose-Response Relationship, Drug; Drug Carriers; Drug Stability; Emulsions; Humans; Inhibitory Concentration 50; Lecithins; Lung; Lung Neoplasms; Particle Size; Polyethylene Glycols; Powders; Solubility; Surface-Active Agents; Technology, Pharmaceutical; Vitamin E | 2015 |
Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Diffusion; Doxorubicin; Lactic Acid; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nanocapsules; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome; Vitamin E | 2015 |
D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Lung Neoplasms; MCF-7 Cells; Mice; Micelles; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Sarcoma; Succinates; Vitamin E | 2015 |
Vitamin E TPGS conjugated carbon nanotubes improved efficacy of docetaxel with safety for lung cancer treatment.
Topics: A549 Cells; Alkaline Phosphatase; Animals; Antineoplastic Agents; Apoptosis; Bronchoalveolar Lavage Fluid; Cell Cycle; Cell Survival; Coated Materials, Biocompatible; Coumarins; Docetaxel; Drug Liberation; Humans; L-Lactate Dehydrogenase; Lung; Lung Neoplasms; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanotubes, Carbon; Rats; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Taxoids; Thiazoles; Vitamin E | 2016 |
Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS.
Topics: A549 Cells; alpha-Tocopherol; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Liberation; Lung Neoplasms; Luteolin; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Vitamin E | 2016 |
Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo.
Topics: A549 Cells; Animals; Apoptosis; Ascorbic Acid; Cell Cycle; Cell Movement; Drug Delivery Systems; Endocytosis; Ginsenosides; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Mice, Nude; Micelles; Succinates; Tumor Burden; Vitamin E | 2017 |
Hyaluronic acid-modified didecyldimethylammonium bromide/ d-a-tocopheryl polyethylene glycol succinate mixed micelles for delivery of baohuoside I against non-small cell lung cancer: in vitro and in vivo evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Flavonoids; Humans; Hyaluronic Acid; Inhibitory Concentration 50; Injections, Intravenous; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Micelles; Paclitaxel; Quaternary Ammonium Compounds; Solubility; Surface Properties; Technology, Pharmaceutical; Time Factors; Vitamin E; Xenograft Model Antitumor Assays | 2017 |
Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Drug Carriers; Humans; Inhibitory Concentration 50; Lung Neoplasms; Magnetic Resonance Spectroscopy; Micelles; Paclitaxel; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Sesquiterpenes; Vitamin E | 2012 |
Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Imines; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Male; Mice; Mice, Nude; Paclitaxel; Poloxalene; Polyethylene Glycols; Polyethylenes; RNA, Small Interfering; Survivin; Vitamin E | 2012 |